Browse > Article

Analysis of cytosine adenine(CA) repeat polymorphism of the IGF-I gene and influence on serum IGF-I levels in healthy children and adolescents  

Ko, Myung Jin (Department of Pediatrics, College of Medicine, Inje University)
Hwang, Tae Gyu (Department of Pediatrics, College of Medicine, Inje University)
Lee, Jeong Nye (Department of Laboratory Medicine, College of Medicine, Inje University)
Chung, Woo Yeong (Department of Pediatrics, College of Medicine, Inje University)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.12, 2006 , pp. 1340-1347 More about this Journal
Abstract
Purpose : The aim of the present study was to investigate the role of polymorphic cytosine adenine (CA) repeat of the IGF-I gene in the age-related alterations of serum IGF-I levels in healthy children. Methods : Two hundred and forty three normal healthy children (136 boys; 107 girls) aged between 7 and 15 years were enrolled in the present study. The primers were designed to cover the promoter regions containing the polymorphic CA repeat. Data were analyzed using GeneMapper software, version 3.7. All analyses were performed using MEDCALC software packages. Results: Deletion of 2 bp (G, A) following 3' of CA repeat were observed in all Korean children. The CA repeat sequences ranged from 17 to 23, and 19 CA repeat were the most common with an alleles frequency of 39.3 percent. Considering genotypes, 63.8 percent of subjects were homozygote or heterozygote for 19 CA repeat (192 bp allele), suggesting that this is wild type allele from which all other alleles originated in Korean children. Homozygote for 19 CA repeat were 14.7 percent, heterozygote for 19 CA repeat was 49.1 percent and 19 CA noncarriers totalled 36.2 percent. In 19 CA repeat noncarriers, the mean height, weight and serum IGF-I level were lower compared with those of 19 CA homozygous carriers, but statistically not significant. Correlations between serum IGF-I level and age according to the IGF-I genotypes revealed statistically significant relationships in the all groups, in the 19 CA repeat carrier group and, even in the noncarrier group. Conclusions : There were no significant differences of the mean height, weight and serum IGF-I levels among three different genotype groups. Also, there were no significantly different correlations between 19 CA repeat polymorphisms and serum IGF-I levels, according to genotype. Our results suggest that the IGF-I 19 CA repeat gene polymorphism is not associated with circulating IGF-I levels in healthy children.
Keywords
Serum; IGF-I level; 19 CA polymorphism; IGF-I gene; Healthy children;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biologicaql actions. Endocr Rev 1995: 16:3-34
2 Miyao M, Hosoi T, Inoue S, Hoshino S, Shiraki M, Orimo H, et al. Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcif Tissue Int 1998;63:306-11   DOI
3 Jernstrom H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, et al. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk. Mol Genet Metabol 2001;72:144-54   DOI   ScienceOn
4 Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birth weight. Lancet 2002;359:1036-7   DOI   ScienceOn
5 Jiang DK, Shen H, Li MX, Jiang C, Yang N, Zhu J, et al. No major effect of the insulin-like growth factor I gene on bone mineral density in premenopausal Chinese women. Bone 2005;36:694-9   DOI   ScienceOn
6 Rietveld I, Janssen JAMJL, van Rossum EFC, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, et al. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol 2004;61:195-203   DOI   ScienceOn
7 Rietveld I, Janssen JAMJL, Hofman A, Pols HAP, van Duijn CM, Lamberts SWJ. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol 2003;148:171-5   DOI   ScienceOn
8 Yang H, Adamo ML, Koval AP, McGuiness MC, Ben-Hur H, Yang Y, et al. Alternative leader sequences in insulin- like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. Endocrinology 1995;9:1380-95   DOI
9 Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-26   DOI
10 Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like factor(IGF)-binding protein-3(IGFBP-3) in healthy infants, children, and adolscents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42   DOI
11 te Velde SJ, van Rossum EF, Voorhoeve PG, Twisk JW, van de Waal AD, Stehouwer CD, et al. An IGF-I promotor polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36. BMC Endocrine Disordes 2005;5:5-13   DOI   ScienceOn
12 Arends N, Hohnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, et al. Polymorphism in the IGF-I gene: Clinical relevance for short children born small for gestational age(SGA). J Clin Endocrinol Metab 2002;87: 2720-4   DOI   ScienceOn
13 Adamo ML. Regulation of insulin-like growth factor I gene expression. Implications for normal and pathological growth. Diabetes Rev 1995;3:2-27
14 Foyt HL, LeRoith D, Roberts Jr CT. Differential association of insulin-like growth factor I mRNA variants with polysomes in vivo. J Biol Chem 1991;266:7300-5
15 Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, et al. Association between serum insulin-like growth factor-I(IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998;83:2286-90   DOI
16 Harrela M, Koinstinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J Clin Invest 1996;98:2612-15   DOI   ScienceOn
17 Kim JG, Roh KR, Lee JY. The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in Korea. Am J Obstet Gynecol 2002;186: 345-50   DOI   ScienceOn
18 Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, et al. A putative fuctional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 2002;51:2313-16   DOI   ScienceOn
19 Day INM. Insulin-like growth factor-I genotype and birth weight. Lancet 2002;360:945
20 Brissenden JE, Ullrich A, Francke U. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature 1984;310:781-4   DOI   ScienceOn
21 Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone(GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369-90   DOI
22 Yu H, Li BDL, Smith M, Shi R, Berkel HJ, Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 2001;70:117-22   DOI   ScienceOn
23 Kao PC, Matheny APJ, Lang CA. Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab 1994;78:310-2   DOI
24 Laron Z. Natural history of the classical form of primary growth hormone(GH) resistance(Laron syndrome). J Pediatr Endocrinol Metab 1999;12(Suppl 1):231-49
25 Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-I:functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50;637-42   DOI   ScienceOn
26 Langford KS, Miell JP. The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation. Eur J Clin Invest 1993;23:503-16   DOI   ScienceOn
27 Takacs I, Koller Dl, Peacock M, Christian JC, Hui SL, Conneally PM, et al. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. J Clin Endocrinol Metab 1999; 84:4467-71   DOI
28 Allen NE, Davey GK, Key TJ, Zhang S, Narod SA. Serum insulin-like growth factor I(IGF-I) concentration in men is not associated with cytosine-adenine repeat polymorphism of the IGF-I gene. Cancer Epidemiol Biomarkers Prev 2002;11:319-20
29 Rotwein P. Sturucture, evolution, expression and regulation of insulin-like growth factors I and II. Growth factors 1991;5:3-18   DOI
30 Mittanck DW, Kim SW, Rotwein P. Essential promoter elments are located within the 5' untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 1997;126:153-63   DOI   ScienceOn
31 Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003;349:1139-47   DOI   ScienceOn